Current Editors: Keith Wagner and Michael Ryan

Past Editors: Tim Allen, Kristyna Gleghorn, Dung Mac, Alex Acosta, William Tausend, Sheila Jalalat, Rebecca Philips, Chelsea Altinger, Lindsey Hunter, Alison Wiesenthal, Leslie Scroggins, Mara Dacso, Ashley Group, Fadi Constantine, Emily Fridlington, Joslyn Witherspoon, Tasneem Poonawalla.

Monday, June 09, 2014

Dermatology Residency Review Committee Expands Resident Logs to Include Medical Management

Beginning July 1, 2014, dermatology residents in ACGME accredited programs will be required to log medical procedures and management that include patch testing and phototherapy, immunobullous and connective tissue diseases, and “high risk systemic medication management.” High risk medications exclude prednisone and isotretinoin, but include “…cyclosporine, methotrexate, acitretin, dapsone, mycophenolate mofetil, TNF antagonists, IL-12/23 antagonists, IL-17 antagonists, rituximab, thalidomide, lenalidomide, cyclophosphamide, daclizumab, ipilimumab, vemurafenib, vismodegib, and other new and emerging molecular-based therapies.” More detailed information about these new requirements may be found here: